Skip to main navigation
  • Investor Home
  • News & Presentations
    News Events Presentations
  • Governance
    Governance Overview Board of Directors Leadership Our ESG Philosophy
  • Financials
    SEC Filings Quarterly Results Annual Reports
  • Stock Information
    Stock Quote & Chart Historic Price Lookup Investment Calculator Analyst Coverage
  • Resources
    Pipeline Investor FAQs Email Alerts Contact IR

Presentations


Featured Presentation

Arcutis April 2026 Corporate Presentation 2.2 MB
Arcutis Fourth Quarter 2025 Financial Results & Business Update 1.6 MB
October 27, 2025
Arcutis Investor Day and Third Quarter 2025 Financial Results
September 19, 2023
Arcutis Biotherapeutics Provides Positive Atopic Dermatitis Program Updates Presentation
December 12, 2022
Arcutis BioTherapeutics Phase 3 Atopic Dermatitis Topline Data Presentation
June 14, 2022
Seborrheic Dermatitis Phase 3 STRATUM Topline Presentation
February 1, 2021
DERMIS-1/DERMIS-2 Phase 3 Plaque Psoriasis Topline Data Review
November 23, 2020
Phase 2b Study of Roflumilast Foam in Adolescents and Adults with Scalp and Body Psoriasis
September 29, 2020
Arcutis Phase 2 Seborrheic Dermatitis Topline Data Call
Print Page
RSS Feeds
Email Alerts
Search
Arcutis Biotherapeutics logo

© 2026 Arcutis Biotherapeutics, Inc. All rights reserved.

  • Image of the Linkedin Logo
  • Image of the Twitter Logo
  • Image of the Instagram Logo
  • Contact
  • Legal Disclaimer
  • Privacy Notice
  • Consumer Health Data Privacy Policy
  • Your Privacy Choices
  • Cookies Settings

© 2026 Arcutis Biotherapeutics, Inc. All rights reserved.